PubMed COVID-19 Clinical Care
56721 - 56730 of 57753 results found
Luciferase-based quantification of membrane fusion induced by SARS CoV2 S protein
Description
The ongoing COVID-19 pandemic is caused by SARS-CoV-2. Although several effective vaccines that target the Spike protein on the viral surface have been deployed, additional therapeutic agents are urgently needed. Here we developed a system to measure
"Reversible cytotoxic lesion of the corpus callosum following SARS-CoV-2 mRNA vaccine administration: a finding to be aware of"
Description
Cytotoxic lesions of the corpus callosum (CLOCCs) are a clinical-radiological spectrum of disorders secondary to several etiopathogeneses. Cytotoxic lesions of the corpus callosum are typically associated with mild clinical symptoms including fever
Role of low-dose tissue plasminogen activator in patients with refractory hypoxia due to presumed microthrombi in pulmonary vasculature in coronavirus disease 2019: A case series and review of the literature
Description
Severe hypoxia due to coronavirus disease 2019 (COVID-19) is challenging in the intensive care unit (ICU). It is often unresponsive to mechanical ventilation at high positive end-expiratory pressure and the fraction of inspired oxygen combination
Blended learning in a biology classroom: Pre-pandemic insights for post-pandemic instructional strategies
Description
It is increasingly important to utilize novel approaches to improve student learning. This has become especially relevant throughout the COVID-19 pandemic. Previous studies have shown positive outcomes of blended learning on student satisfaction. Yet
Safety & effectiveness of COVID-19 vaccines: A narrative review
Description
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the COVID-19 pandemic. Though research is being published all over the
Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study
Description
CONCLUSION: Silent hypoxia may be the only presenting feature of COVID-19. As the case fatality rate is comparable between silent and dyspnoeic hypoxia, it should be recognised early and treated as aggressively. Because home isolation is recommended
Orthostatic hypotonia as a probably late sequela of SARS-CoV-2 infection in a patient provided with palliative home care: a case report
Description
CONCLUSIONS: The occurrence of orthostatic hypotonia seems a possible late sequela of SARS-CoV-2 infection, and simple measures appeared sufficient to achieve sustained symptom control.
Changes in virus detection in hospitalized children before and after the severe acute respiratory syndrome coronavirus 2 pandemic
Description
The impact of strengthening preventive measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the prevalence of respiratory viruses in children was examined. After the SARS-CoV-2 pandemic, the rate of multiple
Social Determinants related to COVID-19 Infection
Description
This study was aimed to identify the social determinants related to COVID-19 infection. This secondary data analysis study used data from 2020 Community Health Survey, a nationwide sample survey to understand the health status of Korean residents
